Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT News, features, and commentary about cancer-related issues Jul 05, 2024
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases? U.S. clinics market oligonucleotide therapy for a wide range of conditions, without much evidence Jul 05, 2024
More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapy Higher BMI also associated with improvements in functional outcomes in this setting Jul 04, 2024
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer Discussion highlights insights from the LAURA trial and others on emerging treatments Jul 03, 2024 video
Vapers May Be Less Likely to Undergo Lung Cancer Screening "Former smokers who use e-cigarettes remain at increased risk of lung cancer," researchers say Jul 02, 2024
PSMA PET Beats MRI in Prostate Cancer Staging Study Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors Jul 02, 2024
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results R-CHOP plus venetoclax falls short, while R-CHOP with HDAC inhibitor shows promise Jul 02, 2024 video
Screening Mammography Performance Improved, Workload Decreased With AI Assistance How European data play out in U.S. mammography environment remains to be seen Jul 01, 2024
Neuromuscular Training Decreased Incidence of Chemo-Induced Peripheral Neuropathy Incidence significantly reduced with two types of exercises versus usual care Jul 01, 2024
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials News, features, and commentary about cancer-related issues Jun 28, 2024
Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria No difference in adverse events, clinical benefit, OS for patients with or without waivers Jun 27, 2024
Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complications Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4 Jun 27, 2024 video
What's a Normal PSA Value for Transgender Women on Estrogen Therapy? Study suggests threshold is too high to identify risk of prostate cancer in this population Jun 26, 2024
Oncology Drug Shortages Persist, but Continue to Evolve Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer Adding the mTOR inhibitor didn't improve EFS in intermediate-risk rhabdomyosarcoma Jun 25, 2024
Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury Case reports may not be as reliable, researchers say Jun 25, 2024
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients Jun 25, 2024 video
Acupuncture Reduced Hot Flashes Related to Endocrine Therapy for Breast Cancer 64% of women reported at least a 50% reduction in hot flash frequency and severity Jun 24, 2024
Subcutaneous C5 Inhibitor Approved for PNH Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
Treating Advanced Breast Cancer After Progression on CDK4/6 Inhibitors Results from postMONARCH offer one path Jun 24, 2024 video
Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverage Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however Jun 24, 2024
Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancer KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer Clinical landscape has shifted away from traditional risks for H&N cancer to HPV predominance Jun 21, 2024
ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types Phase II study found brigatinib exceeded historical control by shrinking 10% of targeted tumors Jun 21, 2024
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer News, features, and commentary about cancer-related issues Jun 21, 2024
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response Jun 20, 2024
Glofitamab Regimen Improves Survival in DLBCL Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
Using MRD Status to Deescalate Multiple Myeloma Therapy Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer New indications for pembrolizumab and durvalumab in advanced disease Jun 17, 2024
New Standard of Care in High-Risk Acute Promyelocytic Leukemia? All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
I Tried to Protect My Mother From Dying in Pain. The Law Robbed Her of That Dignity. It's time to clear the roadblocks to Medical Aid in Dying in the U.S. Jun 16, 2024
Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
Atezolizumab Consolidation Impresses in High-Risk DLBCL Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
Kate Middleton Gives Cancer Update Princess of Wales says she's making "good progress" in treatment Jun 14, 2024
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
